SIGN UP
LOG IN
Q
QLGN
Qualigen Therapeutics Inc
3.48
-0.16-4.51%After Hours: 3.360 -0.12 -3.31%19:26 04/25 EDT
OPEN/PREV CLOSE3.640/3.639
TODAY RANGE3.252-3.645
VOL29.33K
MARKET CAP2.56M
52 WEEK RANGE2.850-29.44
AVG VOL (3M)87.52K
% TURNOVER3.98%
TURNOVER--
P/E (TTM)-0.0619
% RANGE11.49%
EPS(TTM)-56.1107
P/E(FORWARD)-0.0695
P/B-0.8900
BVPS-3.9047
DIVIDEND--
P/S3.797
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.46M
SHARES OUTSTANDING736.43K
NEXT EARNINGS04/25-04/29
FREE FLOAT708.69K
LOT SIZE1
EX-DIV DATE11/05/2024
News
Press Releases
Financial Reports
Profile
Benzinga·04/09 12:07
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·04/03 16:05
Biotech Alert: Searches spiking for these stocks today
TipRanks·04/01 12:22
Qualigen Therapeutics Delays Yearly Financial Report
TipRanks·04/01 12:10
Qualigen Therapeutics enters MOU to acquire Marizyme
TipRanks·03/31 16:40
Biotech Alert: Searches spiking for these stocks today
Benzinga·03/28 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
TipRanks·01/30 16:35
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·01/28 22:48
Qualigen to invest in NanoSynex, stock tumbles 21%
TipRanks·01/28 21:34
Qualigen Therapeutics Invests in NanoSynex’s Growth
TipRanks·01/28 13:15
Qualigen Therapeutics to participate in next funding round for NanoSynex
Benzinga·01/28 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Barchart·12/05/2024 18:24
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price and Equity Requirements
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.